Century Therapeutics appoints Joseph Truitt to its board
Century Therapeutics, Inc. announced the appointment of Joseph Truitt to its board of directors. The company said it develops iPSC-derived cell therapies for autoimmune diseases including type 1 diabetes and cancer.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.